Bridge Biotherapeutics, Inc. (KOSDAQ:288330)

Bridge Biotherapeutics Revenue

Bridge Biotherapeutics had revenue of 1.08M KRW in the quarter ending September 30, 2024, a decrease of -317,747.06%. This brings the company's revenue in the last twelve months to 1.08M, down -99.95% year-over-year. In the year 2023, Bridge Biotherapeutics had annual revenue of 100.00M, down -96.69%.

• Revenue (ttm): 1.08M
• Revenue Growth: -99.95%
• P/S Ratio: n/a
• Revenue / Employee: 30.86K
• Employees: 35
• Market Cap: 217.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	100.00M	-2.92B	-96.69%
Dec 31, 2022	3.02B	1.10B	57.15%
Dec 31, 2021	1.92B	-4.42B	-69.65%
Dec 31, 2020	6.34B	-51.94B	-89.12%
Dec 31, 2019	58.28B	-	-